PHD, Kent State University, 2020, College of Arts and Sciences / School of Biomedical Sciences
Osteoarthritis (OA) is one of the leading causes of disability and is caused by a combination of
mechanical and biochemical factors. Accumulating evidence suggests that inflammation has a key
role in the pathogenesis of OA, and nitric oxide (NO) is considered as one of the major
inflammatory mediators in OA that drives many pathological changes during the development and
progression of OA. Excessive production of NO in chondrocyte promotes cartilage destruction and
cellular injury, and its synthesis in chondrocytes is catalyzed by inducible nitric oxide synthase
(iNOS), which is thereby an attractive therapeutic target for the treatment of OA. A number of
direct and indirect iNOS inhibitors, bioactive compounds, and plant-derived small molecules have
been shown to exhibit a chondroprotective effect by suppressing the expression of iNOS.
Currently, there is no effective disease-modifying drug available for OA. Small molecules have
proved to be powerful tools for modulating important molecular pathways in development and
disease. Our preliminary screening of selected small molecules led us to select imperatorin (IMP)
and peretinoin (PRT), which exhibit anti-inflammatory properties; however, their effect in
chondrocytes is unknown. IMP is a plant-derived compound, while PRT is an acyclic retinoid and
is currently in clinical trials for its efficacy to treat hepato-carcinoma. We found that IMP, as well
as PRT, inhibited IL-1β induced expression of iNOS and production of NO in primary human OA chondrocytes by modulating the activation of mitogen-activated protein kinase (MAPK) pathway.
Additionally, PRT inhibited matrix degradation by suppressing the expression of matrix
metalloproteinase-13 (MMP-13). The work described in this dissertation demonstrates that PRT
inhibits the expression of iNOS and production of NO in primary human OA chondrocytes and
cartilage explants, identifies the mechanism, and shows OA suppressive effects in a mouse OA
model.
Committee: Tariq Haqqi (Advisor); Fayez Safadi (Committee Member); Moses Oyewumi (Committee Member); Mohammad Ansari (Committee Member); Christine Crish (Committee Member)
Subjects: Biomedical Research